• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性肾衰竭患者血小板止血功能的评估]

[Evaluation of platelet hemostasis in patients with chronic renal failure].

作者信息

Krawczyk W, Dmoszyńska A, Sokołowska B

机构信息

Oddziału Chorób Wewnetrznych Szpitala Wojewódzkiego w Chełmie.

出版信息

Wiad Lek. 1994 Feb;47(3-4):93-9.

PMID:7975649
Abstract

The greatest role in the development of haemostasis disturbances in patients with chronic renale failure (CRF) is ascribed to the platelets. The purpose of the work was study of basic parameters of platelet haemostasis in patients with CRF treated both conservatively and subjected to repeated haemodialyses. A correlation was also sought between the degree of renal failure intensity and haemostasis disturbances. The subject of the study were 18 patients treated conservatively and 21 patients subjected to repeated haemodialyses. In the patients the following was determined: platelet count, bleeding time, aggregation by Breddin and Born methods, availability of platelet factor 3 (PF3), activity of platelet factor 4 (PF4), and also the concentrations of urea, creatinine, uric acid, albumins, sodium, potassium, calcium, haemoglobin, and red blood cell count, haematocrit, and endogenous creatinine clearance. In non-dialysed patients, in relation to the control group, unchanged platelet count was shown as well as prolonged bleeding time, increased aggregation assessed by the Breddin method but unchanged by the Born method, decreased PF3 availability and unchanged PF4 activity. Aggregation and bleeding time were correlated with the degree of uraemia progression assessed on the basis of biochemical parameters, while platelet count was correlated only with urea concentration. In haemodialysed patients unchanged platelet count was demonstrated as well as prolonged bleeding time, increased aggregation assessed by the Breddin method but simultaneously decreased in the Born method, increased PF3 availability and unchanged PF4 activity. In this group of patients the correlations were only found between bleeding time and haemoglobin concentration, haematocrit, and red blood cell count.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

慢性肾衰竭(CRF)患者止血功能紊乱的发展中,血小板起了最大作用。本研究的目的是探讨接受保守治疗和反复血液透析的CRF患者血小板止血的基本参数。同时还探寻肾衰竭严重程度与止血功能紊乱之间的相关性。研究对象为18例接受保守治疗的患者和21例接受反复血液透析的患者。测定了患者的以下指标:血小板计数、出血时间、Breddin法和Born法的聚集功能、血小板因子3(PF3)活性、血小板因子4(PF4)活性,以及尿素、肌酐、尿酸、白蛋白、钠、钾、钙、血红蛋白、红细胞计数、血细胞比容和内生肌酐清除率。在未透析患者中,与对照组相比,血小板计数未变,但出血时间延长,Breddin法测定的聚集功能增强而Born法测定的未变,PF3活性降低,PF4活性未变。聚集功能和出血时间与根据生化参数评估的尿毒症进展程度相关,而血小板计数仅与尿素浓度相关。在血液透析患者中,血小板计数未变,但出血时间延长,Breddin法测定的聚集功能增强而Born法测定的同时降低,PF3活性增加,PF4活性未变。在这组患者中,仅发现出血时间与血红蛋白浓度、血细胞比容和红细胞计数之间存在相关性。(摘要截断于250字)

相似文献

1
[Evaluation of platelet hemostasis in patients with chronic renal failure].[慢性肾衰竭患者血小板止血功能的评估]
Wiad Lek. 1994 Feb;47(3-4):93-9.
2
[Evaluation of platelet function during treatment with recombinant human erythropoietin (r-HuEPO) in patients hemodialyzed and dialyzed peritoneally].[重组人促红细胞生成素(r-HuEPO)治疗期间血液透析和腹膜透析患者血小板功能的评估]
Wiad Lek. 1993 Oct;46(19-20):756-60.
3
Platelet function and the bleeding time in progressive renal failure.
Thromb Haemost. 1988 Aug 30;60(1):83-7.
4
[Change of platelet function after the beginning of repeated hemodialysis treatment in patients with uremia].[尿毒症患者开始重复血液透析治疗后血小板功能的变化]
Pol Arch Med Wewn. 1994 Dec;92(6):483-8.
5
The decreased circulating platelet mass and its relation to bleeding time in chronic renal failure.慢性肾衰竭时循环血小板量减少及其与出血时间的关系。
Thromb Haemost. 1991 Jan 23;65(1):11-4.
6
Impact of calcium antagonists on bleeding time in patients with chronic renal failure.钙拮抗剂对慢性肾衰竭患者出血时间的影响。
J Hum Hypertens. 2002 Mar;16(3):199-203. doi: 10.1038/sj.jhh.1001327.
7
Platelet factor 3 in normal subjects and patients with renal failure.正常受试者及肾衰竭患者的血小板第3因子
J Clin Invest. 1968 Apr;47(4):901-12. doi: 10.1172/JCI105782.
8
Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.皮肤出血时间评估尿毒症血小板功能障碍及透析的影响。
Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):185-8. doi: 10.1177/1076029611427438. Epub 2012 Feb 12.
9
Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?慢性肾衰竭及接受肾脏替代治疗患者的脂联素、瘦素与甲状腺激素:它们之间有关联吗?
Nephrol Dial Transplant. 2006 Jan;21(1):145-52. doi: 10.1093/ndt/gfi081. Epub 2005 Sep 2.
10
Platelet function in chronic renal failure.
Acta Univ Carol Med Monogr. 1972;53:333-8.

引用本文的文献

1
Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients.维持性血液透析患者血小板计数、平均血小板体积与血清镁的关系
J Renal Inj Prev. 2012 Jan 1;1(1):17-21. doi: 10.12861/jrip.2012.08. eCollection 2012.